title: Implication of fibrate therapy for homocysteine.
authors.forename: E
authors.initials: E
authors.lastname: Goffin
authors.forename: F
authors.initials: F
authors.lastname: Jamar
authors.forename: J P
authors.initials: JP
authors.lastname: Desager
authors.forename: O
authors.initials: O
authors.lastname: Devuyst
mesh_terms: D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011345:Fenofibrate / Q000494:pharmacology* / Q000627:therapeutic use; D058607:Fibric Acids; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016030:Kidney Transplantation; D017596:Renal Plasma Flow, Effective / Q000187:drug effects
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D006710:Homocysteine; D002995:Clofibric Acid; C019304:ciprofibrate; D011345:Fenofibrate